Jagsonpal Pharmaceuticals Limited (JAGSNPHARM)

212.02

INR
+3.84(+1.84%)
As of March 12, 2025 9:20:00 AM

About Jagsonpal Pharmaceuticals Limited

Jagsonpal Pharmaceuticals Ltd. is a prominent player in the pharmaceutical industry, known for its development, production, and distribution of specialty and generic pharmaceutical drugs. The company's primary function is to manufacture and supply a diverse array of medicinal formulations addressing various therapeutic areas, including pain management, gastroenterology, and gynecology, among others. With a focus on quality and innovation, Jagsonpal Pharmaceuticals continually enhances its product portfolio through rigorous research and development efforts. Operating predominantly in the Indian market, the firm is also expanding its presence internationally, aligning with stringent regulatory standards. The company's contributions to the healthcare sector are significant, as it helps meet the medical needs of a growing population while fostering affordable access to essential drugs. Jagsonpal Pharmaceuticals' strategic efforts to broaden its market presence reflect its ongoing commitment to healthcare advancement and its role as a key contributor in the pharmaceutical supply chain.

RevenueLast 12 months
NA
+NA YoY
EBITDALast 12 months
NA
Price to Sales RatioTTM
5.59
Operating MarginLast 12 months
18.13
+707.2% quarterly YoY
Market Cap
1416.70 CrINR
Employees
1025
CEO
NA
Website